Mestag Announces Licensing of Novel Inflammatory Disease Target
09 Dec 2024 //
GLOBENEWSWIRE
Mestag Therapeutics Expands Leadership & Appoints Key Roles
13 Nov 2024 //
GLOBENEWSWIRE
Merck signs $1.9B deal to explore fibroblast therapies
09 Oct 2024 //
FIERCE BIOTECH
Mestag Announces Collaboration With MSD For Inflammatory Diseases
08 Oct 2024 //
GLOBENEWSWIRE
Mestag Gets £1.5M UK Grant To Develop MST-0300 Cancer Antibody
29 Aug 2024 //
PHARMABIZ
Mestag Presents Preclinical Data at AACR of its M300 Program
08 Apr 2024 //
GLOBENEWSWIRE
Mestag Therapeutics M300 Program Selected for Poster Presentation
05 Mar 2024 //
GLOBENEWSWIRE
Mestag Therapeutics to Present at Evercore ISI 2024 Emerging Biotech Conference
28 Feb 2024 //
GLOBENEWSWIRE
Mestag Therapeutics Enlists Leading Cancer Biology and Immunology Advisors
20 Feb 2024 //
GLOBENEWSWIRE